Get started
Author

Arundhati Nachiket Abhyankar

Observed names: Abhyankar Arundhati, Arundhati Abhyankar, Arundhati N. Abhyankar, Arundhati. N. Abhyankar
Observed institution: Shri Vile Parle Kelavani Mandal
ORCID: 0000-0003-3092-141X
Observed ORCID: 0000-0003-3092-141X
OpenAlex ID: A5068577249
Anti-Tuberculosis Mur Inhibitors: Structural Insights and the Way Ahead for Development of Novel Agents
2023 · Kunal Mehta, Mihir Khambete, et al. · Pharmaceuticals · 26
PDF
Biochemical aspects of hemoglobin-xenobiotic interactions and their implications in drug discovery
2021 · Mehta Gaurav, Ahuja Natesh, et al. · Biochimie · 19
The Evolution of AChE Inhibitors in Alzheimer's Disease: From Single‐Target to Multi‐Target Ligands
2025 · Namrashee V. Mehta, Akshay Kapadia, et al. · ChemBioChem · 14
Elemental exchange: Bioisosteric replacement of phosphorus by boron in drug design
2023 · Namrashee V. Mehta, Arundhati Abhyankar, et al. · European Journal of Medicinal Chemistry · 11
Atropisomerism transforming anti‐cancer drug discovery
2022 · Simran Patel, Khushi Sandha, et al. · Chemical Biology & Drug Design · 11
Monocarbonyl modifications of curcumin: an overview of structure–activity relationship study as anti-infective agents
2025 · Shriya K. Teli, Vasanti M. Suvarna, et al. · Chemical Papers · 2
Enhancing Therapeutic Impact of Curcumins, through Development of Monocarbonyl Analogues of Curcumin for Improved Bioavailability and Activity in Healthcare
2024 · Shriya Krishnaji Teli, Vasanti Madhu Suvarna, et al. · The Natural Products Journal · 1
Exploratory Studies on Anticancer Potential of a Vernonia Species against Colorectal Adenocarcinoma: In Vitro Studies and In Silico Mechanistic Investigations
2022 · Radhika K. Raheja, Arundhati Nachiket Abhyankar
PDF
An Insight Into Privileged Scaffolds in Tuberculosis: Developmental Aspects and Implications in Drug Design
2022 · Rani. A. Shinde, Vasanti. M. Suvarna, et al. · INDIAN DRUGS
Works count: 9
Citation count: 84
H-index: 5
I10-index: 5
Year
Topic
Type